Replies to post #439567 on NorthWest Biotherapeutics Inc (NWBO)

[foxhound02]

This would be no different that what Dendreon did in parallel to getting regulatory approval. Build out manufacturing for a personalized vaccine, which they did. The procedure used for the NW trials is no more laborious than what Dendreon in fact accomplished. Unless, of course they just want to delay to save money until a cheap method is available. Wouldn't that be ethical.

[Doc logic]

HappyLibrarian,

All that discussion has happened too and it is clear demand is expected to ramp much quicker than anything in recent history in the oncology space due to the platform technology it represents which means the kind of manufacturing needed to meet that demand must be readily scalable now. Safety is not an issue so once approved for GBM and rGBM any cancer expressing mesenchymal biomarkers will likely be potential candidates for off label use then approved indications not long after. Direct trials will get almost instant full enrollment and obvious advantage will bee seen in just a few months or less from start of treatment and buildout of capacity takes time even with lots of money involved. If you or others that have been here for any significant amount of time can’t see that this is what is coming by now and that we have had to wait this process out for regulators to get ready too then you probably won’t until after the fact which is a common trait among all of us at one time or another.. Best wishes.

[learningcurve2020]

You'd think with good data in hand a CEO's first priority would be to create a war chest instead of giving away shares depleting authorized and cash, leaving the company prey to a takeover. A strike for common.

And, while we're at it, why would an American CEO agree to have her British manufacturing plant under the roof of the Chinese Communist? Surely there were other deals to be made?? A strike for common.

Advent arrangement another strike for common...


I could continue.